Patents by Inventor Ronald Lee Dahl

Ronald Lee Dahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8568767
    Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: October 29, 2013
    Assignee: Novartis AG
    Inventors: Nils William Ahlgren, Ronald Lee Dahl, Monte Lee Friesen, Alexander Mark Schobel
  • Patent number: 8372426
    Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: February 12, 2013
    Assignee: Novartis Consumer Health S.A.
    Inventors: Nils William Ahlgren, Ronald Lee Dahl, Monte Lee Friesen, Alexander Mark Schobel
  • Publication number: 20120003367
    Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.
    Type: Application
    Filed: September 13, 2011
    Publication date: January 5, 2012
    Applicant: Novartis AG
    Inventors: Nils William AHLGREN, Ronald Lee DAHL, Monte Lee FRIESEN, Alexander Mark SCHOBEL
  • Patent number: 8062659
    Abstract: The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organoleptic properties and is consumable without the need of an ingestion aid.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: November 22, 2011
    Assignee: Novartis AG
    Inventors: Nils William Ahlgren, Ronald Lee Dahl, Monte Lee Friesen, Alexander Mark Schobel